References
- Bargen J A. Experimental studies on the etiology of chronic ulcerative colitis. JAMA 1924; 83: 332–6
- West B, Lendrum R, Hill M J, Walker G. Effects of sul-phasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease. Gut 1974; 15: 960–5
- Keighley M RB, Arabi Y, Dimock F, Burdon D W, Allan R N, Alexander-Williams J. Influence of inflammatory bowel disease on intestinal microflora. Gut 1978; 19: 1099–104
- Cooke E M. Faecal flora of patients with ulcerative colitis during treatment with salicylazosulphapyridine. Gut 1969; 10: 565–8
- Dickinson R J, Varian S A, Axon A TR, Cooke E M. Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis. Gut 1980; 21: 787–92
- Leijonmarck C E, Benno P, Carlstedt-Duke B, et al. The function of the intestinal microflora in patients with ulcerative colitis before and after colectomy. Scand J Gastroenterol 1990; 25: 585–93
- Holdeman L V, Good I J, Moore W EC. Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Appl Environ Microbiol 1976; 31: 359–75
- Simon G L, Gorbach S L. Intestinal flora in health and disease. Gastroenterology 1984; 86: 174–93
- Bennet J D. Ulcerative colitis: the result of an altered bacterial metabolism of bile acids or cholesterol. Med Hypotheses 1986; 20: 125–32
- Midtvedt T. Microbial bile acid transformation. Am J Clin Nutr 1974; 27: 1341–7
- Midtvedt T, Björneklett A, Carlstedt-Duke B, . Germ-free research, microflora control and its application to the biomedical sciences, B S Wostmann, J R Pleasants, M Pollard, B A Teah, M Wagner, et al. Alan R. Liss, New York 1985; 241–4
- Midtvedt T, Lingaas E, Carlstedt-Duke B, et al. Intestinal microbial conversion of cholesterol to coprostanol in man. APMIS 1990; 98: 839–44
- Saxerholt H, Carlstedt-Duke B, Höverstad T, et al. Influence of antibiotics on the faecal excretion of bile pigments in healthy subjects. Scand J Gastroenterol 1986; 21: 991–6
- Norin K E, Carlstedt-Duke B, Höverstad T, et al. Faecal tryptic activity in humans: influence of antibiotics on microbial intestinal degradation. Microbiol Ecology Health Dis 1988; 1: 65–8
- Welling G W, Groen G, Tuinte J H, Koopman J P, Kennis H M. Biochemical effects on germ-free mice of association with several strains of anaerobic bacteria. J Gen Microbiol 1980; 117: 57–63
- Eyssen H J, Parmentier G G, Compernolle F C, De Pauw G, Piessens-Denef M. Biohydrogenation of sterols by Eubacterium ATCC 21,408–nova species. Eur J Biochem 1973; 36: 411–21
- Sadzikowski M R, Sperry J F, Wilkins T D. Cholesterol-reducing bacterium from human feces. Appl Environ Microbiol 1977; 34: 355–62
- Brinkley A W, Gottesman A R, Mott G E. Isolation and characterization of new strains of cholesterol-reducing bacteria from baboons. Appl Environ Microbiol 1982; 43: 86–9
- Kellog T F. On the site of the microbiological reduction of cholesterol to coprostanol in the rat. Lipids 1973; 8: 658–9
- Midtvedt T, Gustafsson B E. Microbial conversion of bilirubin to urobilins in vitro and in vivo. Acta Pathol Microbiol Scand [B] 1981; 89: 57–60
- Norin K E. Germ-free animal characteristics, a study of some functional aspects of intestinal flora in rat and man (thesis). Karolinska Institute, Stockholm 1985
- Norin K E, Midtvedt T, Gustafsson B E. Influence of intestinal microflora on the tryptic activity during lactation in rats. Lab Anim 1986; 21: 621–6
- Welling G W. Beta-aspartylglycine, an indicator of decreased colonization resistance?. New criteria for antimicrobial therapy: maintenance of digestive tract colonization resistance, D van der Waaij, J Verhoef. Excerpta Medica, Amsterdam 1979; 65–72
- Hazenberg M P, Bakker M, Both-Patoir H C, Ruseler-van-Embden J GH, Schröder A M. Effect of sulphasalazine on the human intestinal flora. J Appl Bacteriol 1982; 52: 103–7
- Grisham M B, Granger D N. Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Dig Dis Sci 1988; 33: 6–15
- Verspaget H W, Aparicio-Pagés M N, Verver S, et al. Influence of sulphasalazine and mesalazine on cellular and biochemical oxygen metabolite production. Scand J Gastroenterol 1991; 26: 779–86